AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...
PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence ...
Please provide your email address to receive an email when new articles are posted on . An AI software system improved ultrasound detection of fetal congenital heart defects compared with unaided ...
PARIS, FRANCE / ACCESSWIRE / May 31, 2023 / BrightHeart, a Paris-based medical technology company developing unique artificial intelligence software focused on improving the detection of congenital ...
PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and ...
Background Risk screening for pre-eclampsia relies on accurate gestational age assessment, but routine access to ...
UC San Francisco researchers have found a way to double doctors' accuracy in detecting the vast majority of complex fetal heart defects in utero—when interventions could either correct them or greatly ...
Please provide your email address to receive an email when new articles are posted on . Updated guidance highlights best practices for fetal echocardiography to diagnose congenital heart disease.
For many expectant parents, the ultrasound at around 20 weeks of gestation is a celebration: a look at a baby that now has recognizable features, the chance to learn its sex and a checkmark that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results